NOS2 and infection: Furthermore, the administration of another iNOS inhibitor, L-N6-iminoethyl-lysine, in C57BL/6 mice, which healed their primary L. major infection, resulted in disease recrudescence and a 10-fold increase in parasite burden at both the draining lymph node and cutaneous site of infection.